Log In
Print
BCIQ
Print
Print this Print this
 

ARGX-111

  Manage Alerts
Collapse Summary General Information
Company arGEN-X N.V.
DescriptionC-Met receptor tyrosine kinase antagonist
Molecular Target c-Met receptor tyrosine kinase
Mechanism of Actionc-Met receptor tyrosine kinase inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat c-Met-positive solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today